Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes
Clinical trial NCT00992511 · COMPLETED
Trial details
- NCT number
- NCT00992511
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-14
- Primary completion
- 2010-11-09
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.